OSR Health (OSRHW) Cash & Current Investments (2023 - 2026)
OSR Health (OSRHW) posted Cash & Current Investments of $1.8 million for Q1 2026, down 6.97% sequentially from $2.0 million in Q4 2025, and up 10.66% YoY from $1.7 million in Q1 2025.
OSR Health (OSRHW) Cash & Current Investments (2023 - 2026) Analysis & Trends
OSR Health has reported Cash & Current Investments for 4 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Cash & Current Investments rose 10.66% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 10.66% YoY) and the FY2025 annual result came in at $2.0 million, up 395.75% from the prior year.
- Cash & Current Investments eased to $1.8 million in Q1 2026 per OSRHW's latest filing, from $2.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $70.6 million in Q1 2023 and troughed at $3637.0 in Q1 2024.
- A 4-year average of $7.3 million and a median of $1.6 million in 2025 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 99.99% in 2024, then surged 45273.91% in 2025.
- Over 4 years, Cash & Current Investments stood at $15419.0 in 2023, then jumped by 2468.03% to $395965.0 in 2024, then surged by 395.75% to $2.0 million in 2025, then retreated by 6.97% to $1.8 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $1.8 million, $2.0 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 836.99 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 1.16 Bn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 395,965.00 |
| Sep 30, 2024 | 12,236.00 |
| Mar 31, 2024 | 3,637.00 |
| Dec 31, 2023 | 15,419.00 |
| Sep 30, 2023 | 57,955.00 |
| Mar 31, 2023 | 70.63 Mn |